Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Risankizumab Injection for Psoriasis
Recruiting2 awardsPhase 3
Rolling Meadows, Illinois
This trial will assess the change in disease symptoms of pediatric patients with plaque psoriasis after receiving risankizumab. There are four parts to the study, with the last part being an open-label extension for participants who continue to show improvement.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.